Does higher morning cortisol increase hepatic glucose production and drive higher insulin needs even if HbA1c is normal?

The relationship between morning cortisol and metabolic regulation is well-established, with cortisol acting as a primary driver of the body's early-morning glucose surge. For individuals in older age groups, understanding these dynamics is particularly relevant as metabolic flexibility and hormone regulation can change over time.

Mechanistic basis of glucose production

The morning rise in cortisol is not merely a marker of waking but a functional trigger for hepatic glucose production.

• Enzymatic Activation: Cortisol binds to glucocorticoid receptors in the liver, directly increasing the transcription of rate-limiting gluconeogenic enzymes, specifically phosphoenolpyruvate carboxykinase (PEPCK) and glucose-6-phosphatase (G6Pase).
• Synergistic Effects: This effect is amplified by the presence of glucagon. Glucocorticoids and glucagon work synergistically via cAMP/CREB signaling pathways to maximize the production of glucose as the body prepares for the energy demands of the day.
• Circadian Regulation: Research into circadian proteins like CRY1 shows they act as a "brake" on this process during the night; as CRY1 levels drop in the morning, cortisol-mediated gluconeogenesis is allowed to proceed at full capacity.

Clinical evidence and insulin demand

Elevated cortisol levels necessitate higher insulin production to maintain glucose stability, a state often referred to as "compensated hyperinsulinemia."

• Induced Resistance: Cortisol reduces glucose uptake (glucose disappearance, or Rd) in peripheral tissues like skeletal muscle and adipose tissue while simultaneously increasing hepatic glucose output.
• The "Compensated Phase": In healthy individuals or those with early-stage metabolic shifts, the pancreatic beta-cells increase insulin secretion to overcome this resistance. This keeps plasma glucose levels stable, but at the cost of significantly higher circulating insulin.
• HbA1c Limitations: Because HbA1c measures the average glycation of hemoglobin over 90 days, it is a marker of average blood sugar, not insulin effort. In a study of non-diabetic cohorts, cortisol levels were more strongly correlated with HOMA-IR (a measure of insulin resistance) than with HbA1c. This confirms that insulin demand can rise sharply—reflecting metabolic strain—even while HbA1c remains perfectly within the normal range (<5.7%).

Practical considerations for aging

In a 73-year-old female, the metabolic impact of cortisol may be more pronounced due to age-related changes in body composition and potential shifts in the hypothalamic-pituitary-adrenal (HPA) axis.

• Sarcopenia and Resistance: Since muscle is a primary site for insulin-mediated glucose disposal, age-related loss of muscle mass (sarcopenia) can make the body more sensitive to the insulin-desensitizing effects of morning cortisol.
• Testing Nuance: Standard screening with HbA1c may provide a false sense of metabolic security. If symptoms of insulin resistance (e.g., central adiposity, fatigue) are present despite a normal HbA1c, assessing fasting insulin or HOMA-IR can provide a more accurate picture of the insulin "workload" driven by cortisol.

Bottom line

Higher morning cortisol directly increases hepatic glucose production by upregulating gluconeogenic enzymes. This process drives higher insulin needs because the body must secrete more insulin to maintain euglycemia. Importantly, HbA1c often stays normal during this period because the pancreas is successfully compensating for the resistance, masking the underlying metabolic stress.